These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 6610142

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema.
    Abboud RT, Vimalanathan S.
    Int J Tuberc Lung Dis; 2008 Apr; 12(4):361-7. PubMed ID: 18371259
    [Abstract] [Full Text] [Related]

  • 23. Elastase, collagenase, emphysema, and alpha1-antitrypsin deficiency.
    Lieberman J.
    Chest; 1976 Jul; 70(1):62-7. PubMed ID: 179761
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [New possibilities in the treatment of pulmonary emphysema based on the knowledge of the pathogenetic mechanisms of this disease].
    Krasucka-Kluźniak A.
    Pneumonol Pol; 1983 Oct; 51(10):531-6. PubMed ID: 6361700
    [No Abstract] [Full Text] [Related]

  • 27. [Proteolytic enzymes and their inhibitors in the development of destructive processes in lung diseases].
    Kubyshkin AV.
    Sov Med; 1984 Oct; (9):42-6. PubMed ID: 6209806
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Inhibition of leukocytic elastase from purulent sputum by alpha 1 -antitrypsin.
    Lieberman J, Kaneshiro W.
    J Lab Clin Med; 1972 Jul; 80(1):88-101. PubMed ID: 5033900
    [No Abstract] [Full Text] [Related]

  • 30. Neutrophil recruitment into the lungs is associated with increased lung elastase burden, decreased lung elastin, and emphysema in alpha 1 proteinase inhibitor-deficient mice.
    Cavarra E, Martorana PA, Gambelli F, de Santi M, van Even P, Lungarella G.
    Lab Invest; 1996 Aug; 75(2):273-80. PubMed ID: 8765327
    [Abstract] [Full Text] [Related]

  • 31. Pathogenesis of pulmonary emphysema.
    Flenley DC.
    Q J Med; 1986 Oct; 61(234):901-9. PubMed ID: 3306757
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Pathogenesis of bullous pulmonary emphysema (a review of the literature)].
    Vishnevskiĭ AA, Volkov GM, Nikoladze GD.
    Vrach Delo; 1988 Jul; (7):10-3. PubMed ID: 3055680
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Opportunities for the development of specific therapeutic agents to treat emphysema.
    Cohen AB.
    Am Rev Respir Dis; 1979 Oct; 120(4):723-7. PubMed ID: 389114
    [No Abstract] [Full Text] [Related]

  • 38. Genetic influences in the development of emphysema in persons with normal serum proteins.
    Faling LJ.
    Clin Chest Med; 1983 Sep; 4(3):377-87. PubMed ID: 6357601
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.